William Garrett Nichols, Chief Medical Officer at Candel Therapeutics, Inc. (CADL), sold 90,632 shares at $8.76 ($794K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Scheduled sale ($794k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.76 | 45,316 | $397K | 50.0% |
| 2 | $8.76 | 45,316 | $397K | 50.0% |
| Total | $8.76 avg | 90,632 | $794K | 100% |
| Filing → |
| CADL | SELL | 2025-01-17 | $151K | — | Filing → |
| CADL | SELL | 2025-01-10 | $178K | — | Filing → |
| CADL | SELL | 2024-12-03 | $127K | — | Filing → |